IRAK4-IN-28 |
IRAK4-IN-28 : Inhibitor of IRAK4, IRAK1
Probe Summary
Selectivity
Potency
In Vivo
Control Compounds
Chemical Information
References
Vendors
Download
Probe Summary
| Targets | Biochemical/Biophysical Potency | Cellular Potency |
|---|---|---|
| IRAK4 |
|
|
| IRAK1 |
|
Inhibitor
up to 1 uM
Selectivity
In Vitro Selectivity Assessment
Potency Assay Off-Target:
Millipore kinome selectivity for AZ1495 (%inhibition @ 0.1 μM) 275 kinase. The profile indicated (I ...
Potency Cellular
In Vitro
IRAK4
Mode of Action: Inhibitor
Structure-Activity-Relationship data available? Yes
DOI Reference: 10.1021/acs.jmedchem.7b01290
IRAK1
Mode of Action: Inhibitor
Structure-Activity-Relationship data available? Yes
DOI Reference: 10.1021/acs.jmedchem.7b01290
In Vivo Validations
Rat
Dose: 2 mg/kg
Route of delivery:
Intravenous
Plasma half life:
0.8 h
Systemic clearance:
75 mL/min/kg
Volume of Distribution at Steady-State:
2.1 L/Kg
DOI Reference: 10.1021/acs.jmedchem.7b01290
Dose: 5 mg/kg
Route of delivery:
Oral
Plasma half life:
2.0 h
Bioavailability:
28%
DOI Reference: 10.1021/acs.jmedchem.7b01290
Dog
Dose: 1 mg/kg
Route of delivery:
Intravenous
Plasma half life:
3.3 h
Systemic clearance:
29 mL/min/kg
Volume of Distribution at Steady-State:
3.0 L/Kg
DOI Reference: 10.1021/acs.jmedchem.7b01290
Negative Control Compounds
Chemical Information
| Molecular Formula | C21H31N5O2 |
| SMILEs | c1nc(N[C@H]2CC[C@H](N3CCOCC3)CC2)c2c(C3CCOCC3)c[nH]c2n1 |
| InChI | InChI=1S/C21H31N5O2/c1-3-17(26-7-11-28-12-8-26)4-2-16(1)25-21-19-18(15-5-9-27-10-6-15)13-22-20(19)23-14-24-21/h13-17H,1-12H2,(H2,22,23,24,25)/t16-,17- |
| Molecular weight | 385.25 Da |
| AlogP | 2.9072000000000005 |
| HBond acceptors | 7 |
| HBond donors | 2 |
| Atoms | 59 |
Vendors
Note: This is not an exhaustive list and does not indicate endorsement by the portal.